Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1184 participants.

Also called NCT06548971

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,184 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06548971
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06548971. Randomized; quadruple masking; primary purpose treatment. Start 2024-11-07 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Acronym
TREND-IVT
Condition
Acute Ischemic Stroke
Condition
Cerebral Infarction
Intervention (Drug)
Aspirin
Intervention (Drug)
Placebo
Intervention (Other)
Best medical management
Lead sponsor
Capital Medical University (class: other)

Record details

Record id
cardio:ct-nct06548971
Content hash
52db7e7024648d4944a39aecc54e1ccde240335b77ca537c5cfa43f223dbab5f